Related Experiment Video
Updated: May 9, 2026
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors
Stephen C Frederico1,2, Itay Raphael1, Michal Nisnboym3,4
1Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Objectives:
Despite surgical resection, chemoradiation, and targeted therapy, brain tumors remain a leading cause of cancer-related death in children. Immunotherapy has shown some promise and is actively being investigated for treating childhood brain tumors. However, a critical step in advancing immunotherapy for these patients is to uncover targets that can be effectively translated into therapeutic interventions.
Methods:
In this study, our team performed a transcriptomic analysis across pediatric brain tumor types to identify potential targets for immunotherapy. Additionally, we assessed components that may impact patient response to immunotherapy, including the expression of genes essential for antigen processing and presentation, inhibitory ligands and receptors, interferon signature, and overall predicted T cell infiltration.
Results:
We observed distinct expression patterns across tumor types. These included elevated expression of antigen genes and antigen processing machinery in some tumor types while other tumors had elevated inhibitory checkpoint receptors, known to be associated with response to checkpoint inhibitor immunotherapy.
Conclusion:
These findings suggest that pediatric brain tumors exhibit distinct potential for specific immunotherapies. We believe our findings can guide investigators in their assessment of appropriate immunotherapy classes and targets in pediatric brain tumors.
Insights
Pediatric brain tumors show varied immunotherapy potential. Transcriptomic analysis reveals distinct targets and immune response factors, guiding future treatment strategies for childhood brain cancers.
Area of Science:
- Pediatric oncology
- Cancer immunology
- Transcriptomics
Background:
- Childhood brain tumors are a major cause of cancer death in children.
- Current treatments like surgery, chemoradiation, and targeted therapy have limitations.
- Immunotherapy offers promise but requires identification of effective therapeutic targets.
Purpose of the Study:
- To identify potential immunotherapy targets in pediatric brain tumors through transcriptomic analysis.
- To assess factors influencing immunotherapy response, including antigen processing, immune checkpoints, and T cell infiltration.
- To guide the selection of appropriate immunotherapy classes and targets for pediatric brain tumors.
Main Methods:
- Performed transcriptomic analysis across diverse pediatric brain tumor types.
- Evaluated gene expression related to antigen processing and presentation.
- Assessed expression of inhibitory ligands/receptors, interferon signature, and predicted T cell infiltration.
Main Results:
- Observed distinct gene expression patterns among different pediatric brain tumor types.
- Identified elevated antigen processing machinery in some tumors.
- Found increased expression of inhibitory checkpoint receptors in other tumors, correlating with immunotherapy response.
Conclusions:
- Pediatric brain tumors demonstrate unique potential for specific immunotherapies.
- Findings can inform the selection of immunotherapy strategies and targets.
- This research aids in advancing immunotherapy for childhood brain cancer patients.
